Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation

Intensive Care Medicine

Volumn 37, Issue 3, 2011, Pages 533-541

  Weng, Te I ^a,b   Wu, Hsiao Yi ^a   Kuo, Chia Wei ^a   Liu, Shing Hwa ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Acute lung injury; Animal model; Cecal ligation and puncture; Honokiol; Sepsis

Indexed keywords

3 NITROTYROSINE; ALANINE AMINOTRANSFERASE; AMOXICILLIN PLUS CLAVULANIC ACID; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; HIGH MOBILITY GROUP B1 PROTEIN; HONOKIOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; MALONALDEHYDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTOXEMIA; ENZYME ACTIVATION; GRAM NEGATIVE SEPSIS; INFLAMMATION; LETHALITY; LIPID PEROXIDATION; LUNG EDEMA; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SURVIVAL RATE;

ACUTE LUNG INJURY; ANIMALS; ANTI-INFECTIVE AGENTS; BIPHENYL COMPOUNDS; ENDOTOXEMIA; INFLAMMATION; LIGNANS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED ICR; OXIDATIVE STRESS; SEPSIS;

EID: 79953831820     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-010-2104-1     Document Type: Article

References (40)

1. Shimaoka M, Park EJ (2008) Advances in understanding sepsis. Eur J Anaesthesiol 42(Suppl):146-153 (Pubitemid 351643064)
2. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-251 (Pubitemid 29329996)
3. Abraham E, Nick JA, Azam T, Kim SH, Mira JP, Svetkauskaite D, He Q, Zamora M, Murphy J, Park JS, Overdier K, Dinarello CA (2006) Peripheral blood neutrophil activation patterns are associated with pulmonary inflammatory responses to lipopolysaccharide in humans. J Immunol 176:7753-7760 (Pubitemid 43849076)
4. Abraham E, Carmody A, Shenkar R, Arcaroli J (2000) Neutrophils as early immunologic effectors in hemorrhageor endotoxemia-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 279:L1137-L1145 (Pubitemid 32009500)
5. Silva E, Arcaroli J, He Q, Svetkauskaite D, Coldren C, Nick JA, Poch K, Park JS, Banerjee A, Abraham E (2007) HMGB1 and LPS induce distinct patterns of gene expression and activation in neutrophils from patients with sepsis-induced acute lung injury. Intensive Care Med 33:1829-1839 (Pubitemid 47476646)
6. Asehnoune K, Strassheim D, Mitra S, Kim JY, Abraham E (2004) Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-κB. J Immunol 172:2522-2529 (Pubitemid 38182403)
7. Aderem A, Ulevitch RJ (2000) Toll-like receptors in the induction of the innate immune response. Nature 406:782-787
8. Liang Y, Zhou Y, Shen P (2004) NF-κB and its regulation on the immune system. Cell Mol Immunol 1:343-350
9. Palsson-McDermott EM, O'Neill LA (2004) Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113:153-162
10. Wang H, Yang H, Czura CJ, Sama AE, Tracey KJ (2001) HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med 164:1768-1773 (Pubitemid 33152308)
11. Rauvala H, Rouhiainen A (2007) RAGE as a receptor of HMGB1 (Amphoterin): roles in health and disease. Curr Mol Med 7:725-734
12. Kim JY, Park JS, Strassheim D, Douglas I, Diaz del Valle F, Asehnoune K, Mitra S, Kwak SH, Yamada S, Maruyama I, Ishizaka A, Abraham E (2005) HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mol Physiol 288:L958-L965 (Pubitemid 40547924)
13. Ueno H, Matsuda T, Hashimoto S, Amaya F, Kitamura Y, Tanaka M, Kobayashi A, Maruyama I, Yamada S, Hasegawa N, Soejima J, Koh H, Ishizaka A (2004) Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 170:1310-1316 (Pubitemid 39657195)
14. Li W, Li J, Ashok M, Wu R, Chen D, Yang L, Yang H, Tracey KJ, Wang P, Sama AE, Wang H (2007) A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1. J Immunol 178:3856-3864 (Pubitemid 46417655)
15. Fried L, Arbiser JL (2009) Honokiol, a multifunctional antiangiogenic and antitumor agent. Antioxid Redox Signal 11:1139-1148
16. Son HJ, Lee HJ, Yun-Choi HS, Ryu JH (2000) Inhibitors of nitric oxide synthesis and TNF-α expression from Magnolia obovata in activated macrophages. Planta Med 66:469-471 (Pubitemid 30413511)
17. Taira J, Ikemoto T, Mimura K, Hagi A, Murakami A, Makino K (1993) Effective inhibition of hydroxyl radicals by hydroxylated biphenyl compounds. Free Radic Res Commun 19(Suppl 1):S71-S77 (Pubitemid 24024892)
18. Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA (2009) Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 4:31-36
19. Chiang CK, Sheu ML, Hung KY, Wu KD, Liu SH (2006) Honokiol, a small molecular weight natural product, alleviates experimental mesangial proliferative glomerulonephritis. Kidney Int 70:682-689
20. Chiang J, Shen YC, Wang YH, Hou YC, Chen CC, Liao JF, Yu MC, Juan CW, Liou KT (2009) Honokiol protects rats against eccentric exercise-induced skeletal muscle damage by inhibiting NF-κB induced oxidative stress and inflammation. Eur J Pharmacol 610:119-127
21. Sheu ML, Chiang CK, Tsai KS, Ho FM, Weng TI, Wu HY, Liu SH (2008) Inhibition of NADPH oxidase-related oxidative stress-triggered signaling by honokiol suppresses high glucose-induced human endothelial cell apoptosis. Free Radic Biol Med 44:2043-2050
22. Torun AN, Kulaksizoglu S, Kulaksizoglu M, Pamuk BO, Isbilen E, Tutuncu NB (2009) Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Clin Endocrinol (Oxf) 70:469-474
23. van der Vliet A, Eiserich JP, O'Neill CA, Halliwell B, Cross CE (1995) Tyrosine modification by reactive nitrogen species: a closer look. Arch Biochem Biophys 329:341-349
24. Matthay MA, Zimmerman GA, Esmon C, Bhattacharya J, Coller B, Doerschuk CM, Floros J, Gimbrone MA Jr, Hoffman E, Hubmayr RD, Leppert M, Matalon S, Munford R, Parsons P, Slutsky AS, Tracey KJ, Ward P, Gail DB, Harabin AL (2003) Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 167:1027-1035 (Pubitemid 36408170)
25. Kabir K, Gelinas JP, Chen M, Chen D, Zhang D, Luo X, Yang JH, Carter D, Rabinovici R (2002) Characterization of a murine model of endotoxin-induced acute lung injury. Shock 17:300-303
26. Remick DG, Newcomb DE, Bolgos GL, Call DR (2000) Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock 13:110-116
27. Mishra V (2007) Oxidative stress and role of antioxidant supplementation in critical illness. Clin Lab 53:199-209
28. Chandra A, Enkhbaatar P, Nakano Y, Traber LD, Traber DL (2006) Sepsis: emerging role of nitric oxide and selectins. Clinics (Sao Paulo) 61:71-76
29. Mehta S (2005) The effects of nitric oxide in acute lung injury. Vasc Pharmacol 43:390-403
30. Annane D, Bellissant E, Cavaillon JM (2005) Septic shock. Lancet 365:63-78
31. Okamoto I, Abe M, Shibata K, Shimizu N, Sakata N, Katsuragi T, Tanaka K (2000) Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture. Am J Respir Crit Care Med 162:716-722 (Pubitemid 30647224)
32. Strunk V, Hahnenkamp K, Schneuing M, Fischer LG, Rich GF (2001) Selective iNOS inhibition prevents hypotension in septic rats while preserving endothelium-dependent vasodilation. Anesth Analg 92:681-687
33. Szabó C, Thiemermann C, Wu CC, Perretti M, Vane JR (1994) Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci U S A 91:271-275 (Pubitemid 24018686)
34. Doǧru-Abbasoǧlu S, Parildar-Karpuzoǧlu H, Balkan J, Aykaç-Toker G, Uysal M (2007) Nitrotyrosine formation and heme oxygenase-1 expression in endotoxemic cirrhotic rats. Arch Med Res 38:28-33 (Pubitemid 44894611)
35. Park JS, Arcaroli J, Yum HK, Yang H, Wang H, Yang KY, Choe KH, Strassheim D, Pitts TM, Tracey KJ, Abraham E (2003) Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 284:C870-C879 (Pubitemid 36336943)
36. Sheehan M, Wong HR, Hake PW, Zingarelli B (2003) Parthenolide improves systemic hemodynamics and decreases tissue leukosequestration in rats with polymicrobial sepsis. Crit Care Med 31:2263-2270 (Pubitemid 37100827)
37. Ho KY, Tsai CC, Chen CP, Chen CP, Lin TC, Lin CC (2001) Antimicrobial activity of honokiol and magnolol isolated from Magnolia officinalis. Phytother Res 15:139-141
38. Lee SY, Cho JY (2009) Inhibitory effects of honokiol on LPS and PMA-induced cellular responses of macrophages and monocytes. BMB Rep 42:574-579
39. Lee J, Jung E, Park J, Jung K, Lee S, Hong S, Park J, Park E, Kim J, Park S, Park D (2005) Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-kappaB activation signaling. Planta Med 71:338-343 (Pubitemid 40676458)
40. Chao LK, Liao PC, Ho CL, Wang EI, Chuang CC, Chiu HW, Hung LB, Hua KF (2010) Anti-inflammatory bioactivities of honokiol through inhibition of protein kinase C, mitogen-activated protein kinase, and the NF-κB pathway to reduce LPS-induced TNF-α and NO expression. J Agric Food Chem 58:3472-3478